Alatrash G - Search Results

1

Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ.

O'Shea AE, Clifton GT, Qiao N, Heckman-Stoddard BM, Wojtowicz M, Dimond E, Bedrosian I, Weber D, Garber JE, Husband A, Pastorello R, Lee JJ, Hernandez M, Liu DD, Vornik LA, Brown PH, Alatrash G, Peoples GE, Mittendorf EA. O'Shea AE, et al. Among authors: alatrash g. Cancer Prev Res (Phila). 2023 Jun 1;16(6):333-341. doi: 10.1158/1940-6207.CAPR-22-0388. Cancer Prev Res (Phila). 2023. PMID: 37259799 Free PMC article. Clinical Trial.

2

Cooperation of urokinase plasminogen activator and matrix metalloproteinases in NK cell invasion.

al-Atrash G, Kitson RP, Xue Y, Goldfarb RH. al-Atrash G, et al. In Vivo. 2000 Sep-Oct;14(5):565-70. In Vivo. 2000. PMID: 11125540

3

Rhabdomyolysis after ingestion of "foxy," a hallucinogenic tryptamine derivative.

Alatrash G, Majhail NS, Pile JC. Alatrash G, et al. Mayo Clin Proc. 2006 Apr;81(4):550-1. doi: 10.4065/81.4.550. Mayo Clin Proc. 2006. PMID: 16610577

4

A novel drug delivery system using IL-2 activated NK cells and Zyn-linked doxorubicin.

Goldfarb RH, Koelemij R, Muirhead KA, Ohlsson-Wilhelm BM, Gray BD, Kuppen PJ, Basse PH, al-Atrash G, Kitson RP. Goldfarb RH, et al. In Vivo. 2000 Jan-Feb;14(1):101-4. In Vivo. 2000. PMID: 10757065

5

Cyclic neutropenia associated with T cell immunity to granulocyte proteases and a double de novo mutation in GFI1, a transcriptional regulator of ELANE.

Armistead PM, Wieder E, Akande O, Alatrash G, Quintanilla K, Liang S, Molldrem J. Armistead PM, et al. Among authors: alatrash g. Br J Haematol. 2010 Sep;150(6):716-9. doi: 10.1111/j.1365-2141.2010.08274.x. Br J Haematol. 2010. PMID: 20560965 Free PMC article. No abstract available.

6

uPA and uPAR contribute to NK cell invasion through the extracellular matrix.

Al-Atrash G, Kitson RP, Xue Y, Mazar AP, Kim MH, Goldfarb RH. Al-Atrash G, et al. Anticancer Res. 2001 May-Jun;21(3B):1697-704. Anticancer Res. 2001. PMID: 11497249

7

Combined chemo/anti-angiogenic cancer therapy against Lewis lung carcinoma (3LL) pulmonary metastases.

Datta A, Kitson RP, Xue Y, al-Atrash G, Mazar AP, Jones TR, Goldfarb RH. Datta A, et al. In Vivo. 2002 Nov-Dec;16(6):451-7. In Vivo. 2002. PMID: 12494889

8

IL-2-mediated upregulation of uPA and uPAR in natural killer cells.

Al-Atrash G, Shetty S, Idell S, Xue Y, Kitson RP, Halady PK, Goldfarb RH. Al-Atrash G, et al. Biochem Biophys Res Commun. 2002 Mar 22;292(1):184-9. doi: 10.1006/bbrc.2002.6627. Biochem Biophys Res Commun. 2002. PMID: 11890690

9

Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trials.

Mittendorf EA, Alatrash G, Xiao H, Clifton GT, Murray JL, Peoples GE. Mittendorf EA, et al. Among authors: alatrash g. Expert Rev Vaccines. 2011 Jun;10(6):755-74. doi: 10.1586/erv.11.59. Expert Rev Vaccines. 2011. PMID: 21692698 Review.

10

The role of antigen cross-presentation from leukemia blasts on immunity to the leukemia-associated antigen PR1.

Alatrash G, Ono Y, Sergeeva A, Sukhumalchandra P, Zhang M, St John LS, Yang TH, Ruisaard K, Armistead PM, Mittendorf EA, He H, Qiao N, Rodriguez-Cruz T, Liang S, Clise-Dwyer K, Wieder ED, Lizee G, Lu S, Molldrem JJ. Alatrash G, et al. J Immunother. 2012 May;35(4):309-20. doi: 10.1097/CJI.0b013e31824b3b14. J Immunother. 2012. PMID: 22495388 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page